IFN-$\alpha$-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS

Salem, Mohamed Labib; Zidan, Abdel-Aziz A; El-Naggar, Randa E; Nassef, Mohamed; Abou El-Azm, Abdel Raouf; El-Bate, Hasan; Yussif, Mohamed; Galal, Sohaila; Abo Senna, Mohamed; others; Moustafa, Mohamed said attia;